Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-03-30EMA Authorised: Imuldosa (ustekinumab) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Imuldosa (ustekinumab) from Accord Healthcare S.L.U. for Crohn's disease, psoriasis, and psoriatic …
-
EMA approval · 2026-03-30EMA Authorised: Uzpruvo (ustekinumab) — Stada Arzneimittel AG
EMA authorised Uzpruvo (ustekinumab) for the treatment of psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients [Phase 4]
Phase 4 trial evaluating a GLP-1 receptor agonist with a diet intervention in Crohn's disease; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease [NA]
A clinical trial evaluating cyclic exclusive enteral nutrition as maintenance therapy for pediatric Crohn's disease has completed.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Intestinal Organoids [NA]
Clinical trial update from Rennes University Hospital describes research using intestinal organoids to study inflammatory bowel diseases, in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease [Phase 2]
A Phase 2 clinical trial is investigating the efficacy and safety of SAR442970 in patients with Crohn's disease; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Treatment of Crohn's Complex Perianal Fistulas With Tissue Transplantation by Local Injection of Micro-fragmented Autologous Adipose Tissue. [NA]
A clinical trial update on treating complex perianal fistulas in Crohn's disease using local injection of micro-fragmented autologous adipos…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Development of the SC-IBD Self-Care Measurement Scale
This document reports a clinical trial to develop the SC-IBD Self-Care Measurement Scale for inflammatory bowel diseases, including ulcerati…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]
Phase 2 clinical trial evaluating the long-term effects of TEV-48574 in adults with moderate-to-severe Crohn's disease or ulcerative colitis…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease [Phase 3]
A pediatric Phase 3 trial of mirikizumab (LY3074828) for Crohn's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Efficacy of Different Biological Treatments in Patients With Inflammatory Bowel Disease After One Year of Treatment in Upper Egypt
A clinical trial at Assiut University is evaluating the efficacy of different biological treatments for Crohn's disease and ulcerative colit…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients. [Phase 3]
Phase 3 trial evaluating whether adding the Crohn's Disease Exclusion Diet to standard therapy improves outcomes in unstable pediatric Crohn…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting
A retrospective real-world study sponsored by AbbVie is evaluating treat-to-target strategies and disease modification in adults with Crohn'…
-
EMA approval · 2026-03-25EMA Authorised: Otulfi (ustekinumab) — Fresenius Kabi Deutschland GmbH
EMA authorised Otulfi, a ustekinumab product from Fresenius Kabi Deutschland GmbH, for Crohn's disease and Ulcerative colitis.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease [Phase 2]
This report covers an ongoing Phase 2 clinical trial of Afimkibart (RO7790121) for moderate to severe active Crohn's disease and notes the s…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease [NA]
This clinical trial entry documents a pediatric inflammatory bowel disease study examining the impact of physical activity and fitness. The …
-
EMA label_change · 2026-03-23EMA Authorised: Tremfya — Janssen-Cilag International NV
EU authorises Tremfya to treat psoriasis, Crohn's disease, and ulcerative colitis.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
A prospective observational study assessing the efficacy and safety of guselkumab in Crohn's disease patients who previously received usteki…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD) [NA]
A clinical trial update for AVID-CD evaluating over-the-counter pain medicines to manage discomfort in Crohn's disease, currently recruiting…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy [NA]
This clinical trial compares virtual chromoendoscopy with dye-based chromoendoscopy for surveillance colonoscopy in inflammatory bowel disea…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease
This clinical trial update from the Weizmann Institute of Science describes ongoing research into personalized nutrition, microbiome, and ho…
-
EMA approval · 2026-03-19EMA Authorised: Libmyris (adalimumab) — Stada Arzneimittel AG
EMA authorised Libmyris (adalimumab) by Stada Arzneimittel AG for multiple inflammatory diseases, expanding treatment options in rheumatoid …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease [Phase 2]
A Phase 2 master protocol study sponsored by Eli Lilly evaluating multiple drugs in adults with ulcerative colitis or Crohn's disease; curre…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Combined Immunosuppression for Pediatric Crohn's Disease [Phase 4]
An ongoing Phase 4 clinical trial is evaluating combined immunosuppression for pediatric Crohn's disease using infliximab.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
A Phase 3 study assessing safety, disease activity, and pharmacokinetics of intravenous and subcutaneous risankizumab in pediatric Crohn's d…